{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:36:40Z","timestamp":1786981000770,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR00301"],"award-info":[{"award-number":["UL1TR00301"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005347","name":"American Association for the Study of Liver Diseases","doi-asserted-by":"publisher","award":["50031"],"award-info":[{"award-number":["50031"]}],"id":[{"id":"10.13039\/100005347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK114875"],"award-info":[{"award-number":["DK114875"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL091535"],"award-info":[{"award-number":["HL091535"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10620-025-09237-y","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T09:59:55Z","timestamp":1753523995000},"page":"4247-4258","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Adrenal Dysfunction in Outpatients with Decompensated Cirrhosis: Impairment in the Hypothalamic\u2013Pituitary\u2013Adrenal Axis"],"prefix":"10.1007","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3642-887X","authenticated-orcid":false,"given":"Brian J.","family":"Wentworth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7583-9191","authenticated-orcid":false,"given":"Calvin X.","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5146-7706","authenticated-orcid":false,"given":"Wendy M.","family":"Novicoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8121-9052","authenticated-orcid":false,"given":"Helmy M.","family":"Siragy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1168-7621","authenticated-orcid":false,"given":"Zachary H.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"key":"9237_CR1","doi-asserted-by":"publisher","first-page":"bvac115","DOI":"10.1210\/jendso\/bvac115","volume":"6","author":"BJ Wentworth","year":"2022","unstructured":"Wentworth BJ, Siragy HM. Adrenal insufficiency in cirrhosis. J Endocr Soc. 2022;6:bvac115.","journal-title":"J Endocr Soc"},{"key":"9237_CR2","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1097\/01.CCM.0000164541.12106.57","volume":"33","author":"PE Marik","year":"2005","unstructured":"Marik PE, Gayowski T, Starzl TE. The hepatoadrenal syndrome: a common yet unrecognized clinical condition. Crit Care Med. 2005;33:1254\u20131259.","journal-title":"Crit Care Med"},{"key":"9237_CR3","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1172\/JCI104043","volume":"39","author":"RE Peterson","year":"1960","unstructured":"Peterson RE. Adrenocortical steroid metabolism and adrenal cortical function in liver disease. J Clin Invest. 1960;39:320\u2013331.","journal-title":"J Clin Invest"},{"key":"9237_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1440-1746.1993.tb01195.x","volume":"8","author":"JA McDonald","year":"1993","unstructured":"McDonald JA, Handelsman DJ, Dilworth P et al. Hypothalamic-pituitary adrenal function in end-stage non-alcoholic liver disease. J Gastroenterol Hepatol. 1993;8:247\u2013253.","journal-title":"J Gastroenterol Hepatol"},{"key":"9237_CR5","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/hep.25573","volume":"55","author":"G Fede","year":"2012","unstructured":"Fede G, Spadaro L, Tomaselli T et al. Adrenocortical dysfunction in liver disease: a systematic review. Hepatology. 2012;55:1282\u20131291.","journal-title":"Hepatology"},{"key":"9237_CR6","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1111\/liv.14970","volume":"41","author":"BJ Wentworth","year":"2021","unstructured":"Wentworth BJ, Haug RM, Northup PG et al. Abnormal cholesterol metabolism underlies relative adrenal insufficiency in decompensated cirrhosis. Liver Int. 2021;41:1913\u20131921.","journal-title":"Liver Int"},{"key":"9237_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12876-017-0614-9","volume":"17","author":"T Kaiser","year":"2017","unstructured":"Kaiser T, Kinny-K\u00f6ster B, Bartels M et al. Cholesterol esterification in plasma as a biomarker for liver function and prediction of mortality. BMC Gastroenterol. 2017;17:57.","journal-title":"BMC Gastroenterol"},{"key":"9237_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0026-0495(93)90166-L","volume":"42","author":"D Tahara","year":"1993","unstructured":"Tahara D, Nakanishi T, Akazawa S et al. Lecithin-cholesterol acyltransferase and lipid transfer protein activities in liver disease. Metabolism. 1993;42:19\u201323.","journal-title":"Metabolism"},{"key":"9237_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090967","volume":"9","author":"AE Bochem","year":"2014","unstructured":"Bochem AE, Holleboom AG, Romijn JA et al. Adrenal function in females with low plasma HDL-C due to mutations in ABCA1 and LCAT. PLoS One. 2014;9:e90967.","journal-title":"PLoS One"},{"key":"9237_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cyto.2015.10.006","volume":"77","author":"M Dirchwolf","year":"2016","unstructured":"Dirchwolf M, Podhorzer A, Marino M et al. Immune dysfunction in cirrhosis: distinct cytokines phenotypes according to cirrhosis severity. Cytokine. 2016;77:14\u201325.","journal-title":"Cytokine"},{"key":"9237_CR11","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1002\/hep.26535","volume":"58","author":"J Acevedo","year":"2013","unstructured":"Acevedo J, Fernandez J, Prado V et al. Relative adrenal insufficiency in decompensated cirrhosis: relationship to short-term risk of severe sepsis, hepatorenal syndrome, and death. Hepatology. 2013;58:1757\u20131765.","journal-title":"Hepatology"},{"key":"9237_CR12","doi-asserted-by":"publisher","first-page":"584","DOI":"10.5604\/01.3001.0010.0298","volume":"16","author":"E Cholongitas","year":"2017","unstructured":"Cholongitas E, Goulis I, Pagkalidou E et al. Relative adrenal insufficiency is associated with the clinical outcome in patients with stable decompensated cirrhosis. Ann Hepatol. 2017;16:584\u2013590.","journal-title":"Ann Hepatol"},{"key":"9237_CR13","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.cgh.2019.09.035","volume":"18","author":"S Piano","year":"2020","unstructured":"Piano S, Favaretto E, Tonon M et al. Including relative adrenal insufficiency in definition and classification of acute-on-chronic liver failure. Clin Gastroenterol Hepatol. 2020;18:1188-1196.e3.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9237_CR14","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/hep.21101","volume":"43","author":"MH Tsai","year":"2006","unstructured":"Tsai MH, Peng YS, Chen YC et al. Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock. Hepatology. 2006;43:673\u2013681.","journal-title":"Hepatology"},{"key":"9237_CR15","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1177\/1060028019900266","volume":"54","author":"T Vu","year":"2020","unstructured":"Vu T, Vallabh M, Laine G. Adrenal insufficiency and response to stress dose hydrocortisone in patients with cirrhosis and vasopressor dependency using cirrhosis-specific cortisol thresholds. Ann Pharmacother. 2020;54:742\u2013749.","journal-title":"Ann Pharmacother"},{"key":"9237_CR16","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1503\/cmaj.090707","volume":"182","author":"YM Arabi","year":"2010","unstructured":"Arabi YM, Aljumah A, Dabbagh O et al. Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial. CMAJ. 2010;182:1971\u20131977.","journal-title":"CMAJ"},{"key":"9237_CR17","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1002\/hep.21352","volume":"44","author":"J Fernandez","year":"2006","unstructured":"Fernandez J, Escorsell A, Zabalza M et al. Adrenal insufficiency in patients with cirrhosis and septic shock: effect of treatment with hydrocortisone on survival. Hepatology. 2006;44:1288\u20131295.","journal-title":"Hepatology"},{"key":"9237_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1034\/j.1600-0676.2003.00813.x","volume":"23","author":"R Harry","year":"2003","unstructured":"Harry R, Auzinger G, Wendon J. The effects of supraphysiological doses of corticosteroids in hypotensive liver failure. Liver Int. 2003;23:71\u201377.","journal-title":"Liver Int"},{"key":"9237_CR19","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1210\/jc.2007-0737","volume":"93","author":"E Badrick","year":"2008","unstructured":"Badrick E, Bobak M, Britton A et al. The relationship between alcohol consumption and cortisol secretion in an aging cohort. J Clin Endocrinol Metab. 2008;93:750\u2013757.","journal-title":"J Clin Endocrinol Metab"},{"key":"9237_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1177\/0706743716632512","volume":"61","author":"SK Blaine","year":"2016","unstructured":"Blaine SK, Milivojevic V, Fox H et al. Alcohol effects on stress pathways: Impact on craving and relapse risk. Can J Psychiatry. 2016;61:145\u2013153.","journal-title":"Can J Psychiatry"},{"key":"9237_CR21","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.eprac.2022.04.003","volume":"28","author":"L Zha","year":"2022","unstructured":"Zha L, Li J, Krishnan SM et al. New diagnostic cutoffs for adrenal insufficiency after cosyntropin stimulation using Abbott Architect cortisol immunoassay. Endocr Pract. 2022;28:684\u2013689.","journal-title":"Endocr Pract"},{"key":"9237_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.clinbiochem.2018.02.010","volume":"54","author":"V Munro","year":"2018","unstructured":"Munro V, Elnenaei M, Doucette S et al. The effect of time of day testing and utility of 30 and 60 minute cortisol values in the 250 mcg ACTH stimulation test. Clin Biochem. 2018;54:37\u201341.","journal-title":"Clin Biochem"},{"key":"9237_CR23","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/liv.15473","volume":"43","author":"BJ Wentworth","year":"2023","unstructured":"Wentworth BJ, Schliep M, Novicoff W et al. Relative adrenal insufficiency in the non-critically ill patient with cirrhosis: a systematic review and meta-analysis. Liver Int. 2023;43:660\u2013672.","journal-title":"Liver Int"},{"key":"9237_CR24","doi-asserted-by":"publisher","first-page":"bvab022","DOI":"10.1210\/jendso\/bvab022","volume":"5","author":"BR Javorsky","year":"2021","unstructured":"Javorsky BR, Raff H, Carroll TB et al. New cutoffs for the biochemical diagnosis of adrenal insufficiency after ACTH stimulation using specific cortisol assays. J Endocr Soc. 2021;5:bvab022.","journal-title":"J Endocr Soc"},{"key":"9237_CR25","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae855","author":"AJ Han","year":"2024","unstructured":"Han AJ, Suresh M, Gruber L et al. Performance of dehydroepiandrosterone sulfate and baseline cortisol in assessing adrenal insufficiency. J Clin Endocrinol Metab. 2024. https:\/\/doi.org\/10.1210\/clinem\/dgae855.","journal-title":"J Clin Endocrinol Metab"},{"key":"9237_CR26","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jhep.2010.05.020","volume":"53","author":"T Tan","year":"2010","unstructured":"Tan T, Chang L, Woodward A et al. Characterising adrenal function using directly measured plasma free cortisol in stable severe liver disease. J Hepatol. 2010;53:841\u2013848.","journal-title":"J Hepatol"},{"key":"9237_CR27","doi-asserted-by":"publisher","first-page":"268","DOI":"10.5152\/tjg.2016.15544","volume":"27","author":"F Araz","year":"2016","unstructured":"Araz F, Soyda\u015f B, \u00d6zer B et al. The importance of salivary cortisol in the diagnosis of adrenal insufficiency in cirrhosis. Turk J Gastroenterol. 2016;27:268\u2013272.","journal-title":"Turk J Gastroenterol"},{"key":"9237_CR28","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1007\/s10620-019-5460-x","volume":"64","author":"E Theocharidou","year":"2019","unstructured":"Theocharidou E, Giouleme O, Anastasiadis S et al. Free cortisol is a more accurate marker for adrenal function and does not correlate with renal function in cirrhosis. Dig Dis Sci. 2019;64:1686\u20131694. https:\/\/doi.org\/10.1007\/s10620-019-5460-x","journal-title":"Dig Dis Sci"},{"key":"9237_CR29","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1177\/0004563218755817","volume":"55","author":"H Emms","year":"2018","unstructured":"Emms H, Farah G, Shine B et al. Falsely elevated plasma metanephrine in patients taking midodrine. Ann Clin Biochem. 2018;55:509\u2013515.","journal-title":"Ann Clin Biochem"},{"key":"9237_CR30","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.4254\/wjh.v7.i8.1112","volume":"7","author":"AK Karagiannis","year":"2015","unstructured":"Karagiannis AK, Nakouti T, Pipili C et al. Adrenal insufficiency in patients with decompensated cirrhosis. World J Hepatol. 2015;7:1112\u20131124.","journal-title":"World J Hepatol"},{"key":"9237_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1210\/endo-127-1-101","volume":"127","author":"RC Gaillard","year":"1990","unstructured":"Gaillard RC, Turnill D, Sappino P et al. Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors. Endocrinology. 1990;127:101\u2013106.","journal-title":"Endocrinology"},{"key":"9237_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/1479-5876-9-113","volume":"9","author":"HO Kim","year":"2011","unstructured":"Kim HO, Kim HS, Youn JC et al. Serum cytokine profiles in healthy young and elderly population assessed using multiplexed bead-based immunoassays. J Transl Med. 2011;9:113.","journal-title":"J Transl Med"},{"key":"9237_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/434010","volume":"2013","author":"G Kleiner","year":"2013","unstructured":"Kleiner G, Marcuzzi A, Zanin V et al. Cytokine levels in the serum of healthy subjects. Mediators Inflamm. 2013;2013:434010.","journal-title":"Mediators Inflamm"},{"key":"9237_CR34","doi-asserted-by":"publisher","first-page":"E433","DOI":"10.1152\/ajpendo.00074.2003","volume":"285","author":"A Steensberg","year":"2003","unstructured":"Steensberg A, Fischer CP, Keller C, M\u00f8ller K, Pedersen BK. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol Endocrinol Metab. 2003;285:E433\u2013E437.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"9237_CR35","first-page":"E813","volume":"268","author":"JM Stouthard","year":"1995","unstructured":"Stouthard JM, Romijn JA, Van der Poll T et al. Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol. 1995;268:E813\u2013E819.","journal-title":"Am J Physiol"},{"key":"9237_CR36","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1159\/000125884","volume":"54","author":"K Lyson","year":"1991","unstructured":"Lyson K, McCann SM. The effect of interleukin-6 on pituitary hormone release in vivo and in vitro. Neuroendocrinology. 1991;54:262\u2013266.","journal-title":"Neuroendocrinology"},{"key":"9237_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1677\/joe.0.1220033","volume":"122","author":"J Fukata","year":"1989","unstructured":"Fukata J, Usui T, Naitoh Y et al. Effects of recombinant human interleukin-1 alpha, -1 beta, 2 and 6 on ACTH synthesis and release in the mouse pituitary tumour cell line AtT-20. J Endocrinol. 1989;122:33\u201339.","journal-title":"J Endocrinol"},{"key":"9237_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155654","volume":"146","author":"T Korn","year":"2021","unstructured":"Korn T, Hiltensperger M. Role of IL-6 in the commitment of T cell subsets. Cytokine. 2021;146:155654.","journal-title":"Cytokine"},{"key":"9237_CR39","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jhep.2012.03.007","volume":"57","author":"JC Garc\u00eda-Pag\u00e1n","year":"2012","unstructured":"Garc\u00eda-Pag\u00e1n JC, Gracia-Sancho J, Bosch J. Functional aspects on the pathophysiology of portal hypertension in cirrhosis. J Hepatol. 2012;57:458\u2013461.","journal-title":"J Hepatol"},{"key":"9237_CR40","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/hep.22063","volume":"47","author":"M Charlton","year":"2008","unstructured":"Charlton M, Angulo P, Chalasani N et al. Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease. Hepatology. 2008;47:484\u2013492.","journal-title":"Hepatology"},{"key":"9237_CR41","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s13054-017-1768-0","volume":"21","author":"MH Tsai","year":"2017","unstructured":"Tsai MH, Huang HC, Peng YS et al. Dehydroepiandrosterone sulfate and dehydroepiandrosterone sulfate\/cortisol ratio in cirrhotic patients with septic shock: another sign of hepatoadrenal syndrome? Crit Care. 2017;21:214.","journal-title":"Crit Care"},{"key":"9237_CR42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5005\/japi-11001-0110","volume":"70","author":"M Singhal","year":"2022","unstructured":"Singhal M, Sharma S, Tom NB et al. A study of adrenal insufficiency in hemodynamically stable patients with cirrhosis. J Assoc Physicians India. 2022;70:11\u201312.","journal-title":"J Assoc Physicians India"},{"key":"9237_CR43","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/hep.510300303","volume":"30","author":"D Ackermann","year":"1999","unstructured":"Ackermann D, Vogt B, Escher G et al. Inhibition of 11beta-hydroxysteroid dehydrogenase by bile acids in rats with cirrhosis. Hepatology. 1999;30:623\u2013629.","journal-title":"Hepatology"},{"key":"9237_CR44","first-page":"748","volume":"76","author":"PM Stewart","year":"1993","unstructured":"Stewart PM, Burra P, Shackleton CH et al. 11 beta-Hydroxysteroid dehydrogenase deficiency and glucocorticoid status in patients with alcoholic and non-alcoholic chronic liver disease. J Clin Endocrinol Metab. 1993;76:748\u2013751.","journal-title":"J Clin Endocrinol Metab"},{"key":"9237_CR45","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0016-5085(98)70645-6","volume":"114","author":"G Escher","year":"1998","unstructured":"Escher G, Nawrocki A, Staub T et al. Down-regulation of hepatic and renal 11 beta-hydroxysteroid dehydrogenase in rats with liver cirrhosis. Gastroenterology. 1998;114:175\u2013184.","journal-title":"Gastroenterology"},{"key":"9237_CR46","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/apt.12891","volume":"40","author":"JY Jang","year":"2014","unstructured":"Jang JY, Kim TY, Sohn JH et al. Relative adrenal insufficiency in chronic liver disease: its prevalence and effects on long-term mortality. Aliment Pharmacol Ther. 2014;40:819\u2013826.","journal-title":"Aliment Pharmacol Ther"},{"key":"9237_CR47","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1111\/ajt.15559","volume":"19","author":"EL Godfrey","year":"2019","unstructured":"Godfrey EL, Malik TH, Lai JC et al. The decreasing predictive power of MELD in an era of changing etiology of liver disease. Am J Transplant. 2019;19:3299\u20133307.","journal-title":"Am J Transplant"},{"key":"9237_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100789","volume":"5","author":"L Hartl","year":"2023","unstructured":"Hartl L, Simbrunner B, Jachs M et al. An impaired pituitary-adrenal signalling axis in stable cirrhosis is linked to worse prognosis. JHEP Rep. 2023;5:100789.","journal-title":"JHEP Rep"},{"key":"9237_CR49","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jhep.2020.08.009","volume":"74","author":"E Sol\u00e0","year":"2021","unstructured":"Sol\u00e0 E, Pose E, Campion D et al. Endpoints and design of clinical trials in patients with decompensated cirrhosis: position paper of the LiverHope Consortium. J Hepatol. 2021;74:200\u2013219.","journal-title":"J Hepatol"},{"key":"9237_CR50","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1478-3231.2010.02431.x","volume":"31","author":"T Thevenot","year":"2011","unstructured":"Thevenot T, Borot S, Remy-Martin A et al. Assessment of adrenal function in cirrhotic patients using concentration of serum-free and salivary cortisol. Liver Int. 2011;31:425\u2013433.","journal-title":"Liver Int"},{"key":"9237_CR51","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1111\/j.1440-1746.2012.07188.x","volume":"27","author":"T Thevenot","year":"2012","unstructured":"Thevenot T, Dorin R, Monnet E et al. High serum levels of free cortisol indicate severity of cirrhosis in hemodynamically stable patients. J Gastroenterol Hepatol. 2012;27:1596\u20131601.","journal-title":"J Gastroenterol Hepatol"},{"key":"9237_CR52","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1111\/acer.13515","volume":"41","author":"M Comerford","year":"2017","unstructured":"Comerford M, Lourens S, Liangpunsakul S et al. Challenges in patient enrollment and retention in clinical studies for alcoholic hepatitis: experience of the TREAT Consortium. Alcohol Clin Exp Res. 2017;41:2000\u20132006.","journal-title":"Alcohol Clin Exp Res"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09237-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09237-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09237-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T17:02:36Z","timestamp":1765299756000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09237-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9237"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09237-y","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This prospective cohort study was approved by the institutional review board of the University of Virginia as exempt study IRB-HSR #200392.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients provided written consent for participation in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for participation"}},{"value":"This study was registered on ClinicalTrials.gov as NCT04642391.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration"}}]}}